<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13-viruses-12-00904">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Burgueno</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Reich</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hazime</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Quintero</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Fernandez</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Fritsch</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Abreu</surname>
    <given-names>M.T.</given-names>
   </name>
  </person-group>
  <article-title>Expression of SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in the gut of patients with IBD</article-title>
  <source>Inflamm. Bowel Dis.</source>
  <year>2020</year>
  <volume>26</volume>
  <fpage>797</fpage>
  <lpage>808</lpage>
  <pub-id pub-id-type="doi">10.1093/ibd/izaa085</pub-id>
  <?supplied-pmid 32333601?>
  <pub-id pub-id-type="pmid">32333601</pub-id>
 </element-citation>
</ref>
